삼성서울병원

Ko En

Gastroenterology Kang, Wonseok M.D , Ph.D

Expertise
Primary liver cancer, cirrhosis, viral hepatitis, non-alcoholic fatty liver disease
Treament Schedule 04 月
DATE
MON
01
TUE
02
WEB
03
THU
04
FRI
05
SAT
06
SUN
07
MON
08
TUE
09
WEB
10
THU
11
FRI
12
SAT
13
SUN
14
MON
15
TUE
16
WEB
17
THU
18
FRI
19
SAT
20
SUN
21
MON
22
TUE
23
WEB
24
THU
25
FRI
26
SAT
27
SUN
28
MON
29
TUE
30
AM
PM
Treament Schedule 05 月
DATE
WEB
01
THU
02
FRI
03
SAT
04
SUN
05
MON
06
TUE
07
WEB
08
THU
09
FRI
10
SAT
11
SUN
12
MON
13
TUE
14
WEB
15
THU
16
FRI
17
SAT
18
SUN
19
MON
20
TUE
21
WEB
22
THU
23
FRI
24
SAT
25
SUN
26
MON
27
TUE
28
WEB
29
THU
30
FRI
31
AM
PM

Medical Education

2009~2013 Ph.D. in Biomedical Science, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Korea
2004~2009 Master of Medical Science, Yonsei University College of Medicine, Seoul, Korea
1998~2004 M.D., Yonsei University College of Medicine, Seoul, Korea

Post-Graduate Training

Fellowship   2013~2014 Severance Hospital, Yonsei University, Seoul, Korea
Residency   2005~2009 Severance Hospital, Yonsei University, Seoul, Korea
Internship   2004~2005 Severance Hospital, Yonsei University, Seoul, Korea

Professional Appointments

2021~Present Associate Professor, Gastroenterology, Sungkyunkwan University School of Medicine, Seoul, Korea
2016~2021 Assistant Professor, Gastroenterology, Sungkyunkwan University School of Medicine, Seoul, Korea
2015~2016 Assistant Professor, Gastroenterology, Samsung Medical Center, Seoul, Korea
2015.03~2015.08 Research Assistant Professor, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
2014~2015 Clinical Instructor, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
2013.03~2013.04 Appointed researcher, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Korea

Professional Memberships

Member, Korean Association for the Study of the Liver (KASL)
Member, The Korean Liver Cancer Association (KLCA)
Member, The Korean Society of Gastroenterology (KSG)
Member, The Asia-Pacific Primary Liver Cancer Expert (APPLE) Association
Member, American Association for the Study of Liver Diseases (AASLD)
Member, American Association for Cancer Research (AACR)
Member, International Liver Cancer Association (ILCA)

Selected Publications

  • J CLIN APHERESIS 2021 10.1002/jca.21873 Initial experience with high-volume plasma exchange in patients with acute liver failure Kim1, JE; Chun, S; Sinn, DH; Kim, NJ; Kim, S; Kang, W; Kim, JM; Choi, GS; Joh, JW; Cho, D
    View PubMed
  • EUR J CANCER 2021 10.1016/j.ejca.2021.03.024 Association between non-alcoholic fatty liver disease and the risk of biliary tract cancers: A South Korean nationwide cohort study Park1, JH; Hong, JY; Kwon, M; Lee, J; Han, K; Han, IW; Kang, W; Park, JK
    View PubMed
  • J HEPATOCELL CARCINO 2021 10.2147/JHC.S304439 Clinical Characteristics of Long-Term Survivors After Sorafenib Treatment for Unresectable Hepatocellular Carcinoma: A Korean National Multicenter Retrospective Cohort Study Cho1, YY; Yu, SJ; Lee, HW; Kim, DY; Kang, W; Paik, YH; Sung, PS; Bae, SH; Park, SC; Doh, YS; Kim, KM; Jang, ES; Kim, IH; Kim, W; Kim, YJ
    View PubMed
  • NUTRIENTS 2021 10.3390/nu13031013 Characterization of Gut Microbiome in Korean Patients with Metabolic Associated Fatty Liver Disease Oh1, JH; Lee, JH; Cho, MS; Kim, H; Chun, J; Lee, JH; Yoon, Y; Kang, W
    View PubMed
  • DIGEST LIVER DIS 2021 10.1016/j.dld.2020.10.030 A comparison of factors associated with the temporal improvement in the overall survival of BCLC stage 0 hepatocellular carcinoma patients Song1, BG; Kim, MJ; Sinn, DH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed